Jean-Marie Eveillard - First Eagle Investment Management
Holding/activity history for Quest Diagnostics Inc. (DGX)
← All DGX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 3,000 | <0.01 | Reduce 23.76% | <0.01 | $171.18–213.50 · VW $195.58i | $587,940 | SEC |
| 2025 Q4 | 3,935 | <0.01 | Add 2.61% | $173.39–197.55 · VW $182.48i | $682,841 | SEC | |
| 2025 Q3 | 3,835 | <0.01 | Reduce 32.68% | <0.01 | $164.65–191.49 · VW $176.77i | $730,874 | SEC |
| 2025 Q2 | 5,697 | <0.01 | Add 2.67% | <0.01 | $157.20–182.38 · VW $173.63i | $1,023,353 | SEC |
| 2025 Q1 | 5,549 | <0.01 | Add 12.12% | <0.01 | $148.70–178.87 · VW $166.80i | $938,891 | SEC |
| 2024 Q4 | 4,949 | <0.01 | $150.86 | $746,606 | SEC | ||
| 2024 Q3 | 4,949 | <0.01 | Add 11.24% | <0.01 | $136.30–159.36 · VW $149.07i | $768,333 | SEC |
| 2024 Q2 | 4,449 | <0.01 | Add 15.59% | <0.01 | $125.42–145.62 · VW $138.01i | $608,979 | SEC |
| 2024 Q1 | 3,849 | <0.01 | $133.11 | $512,341 | SEC | ||
| 2023 Q4 | 3,849 | <0.01 | $137.88 | $530,700 | SEC | ||
| 2023 Q3 | 3,849 | <0.01 | Add 4.85% | <0.01 | $121.73–145.58 · VW $132.33i | $469,039 | SEC |
| 2023 Q2 | 3,671 | <0.01 | $140.56 | $515,996 | SEC | ||
| 2023 Q1 | 3,671 | <0.01 | Add 1239.78% | <0.01 | $130.34–157.36 · VW $142.58i | $519,373 | SEC |
| 2022 Q4 | 274 | <0.01 | Reduce 8.36% | $122.05–158.34 · VW $146.25i | $42,865 | SEC | |
| 2022 Q3 | 299 | <0.01 | Add 128.24% | <0.01 | $120.40–142.84 · VW $129.87i | $37,000 | SEC |
| 2022 Q2 | 131 | 0.00 | $129.77 | $17,000 | SEC | ||
| 2022 Q1 | 131 | 0.00 | Buy | $125.77–172.50 · VW $138.93i | $18,000 | SEC |
Price snapshot:
Current price$207.35
Avg. buy price$145.66
+/- since buy42.35%
52-week low$161.81
52-week high$218.31